Besponsa® Clinical Papers

Use the links below to access Besponsa® clinical papers

1. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukaemia; Kantarjian HM et al. NEJM 2016; 375: 740-753

Link to download paper

This clinical paper has been certified by Pfizer Ltd. in accordance with the ABPI Code of Practice and contains promotional information and is intended for UK Healthcare Professionals. PP-INO-GBR-0370. March 2020

2. Management of important adverse events associated with inotuzumab ozogamicin: expert panel review; Kebriaei P, et al. Bone Marrow Transplant 2018;53:449–456

Link to download paper

This clinical paper has been certified by Pfizer Ltd. in accordance with the ABPI Code of Practice and contains promotional information and is intended for UK Healthcare Professionals. PP-INO-GBR-0369. March 2020

3. Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment; Marks DI et al. Cancer Medicine. 2019;8 :5959-5968.

Link to download paper

This clinical paper has been certified by Pfizer Ltd. in accordance with the ABPI Code of Practice and contains promotional information and is intended for UK Healthcare Professionals. PP-INO-GBR-0365. March 2020

PP-INO-GBR-0290. May 2020